Craigavon
CRAIGAVON, Northern Ireland, May 11, 2011 - Almac is hosting its inaugural European Product Launch
workshop in Boston, MA on 17th May 2011.
CRAIGAVON, Northern Ireland, May 6, 2011 - Almac's Clinical Technologies business unit announced today that Todd
Kole has joined the Company as Vice President of Clinical Project Services
(CPS) and a member of the Executive Leadership Team.
CRAIGAVON, Northern Ireland, May 4, 2011 - As anticipated, Almac's biocatalysis business has expanded
from its 2009 launch with the sale of six enzyme screening kits, to the
current supply of 100s of kgs of chiral intermediates for drug substance
manufacture, regular enzyme supply to specialty chemical companies and
continued growth of its screening kits offering.
CRAIGAVON, NI, April 11, 2011 - The Almac Group, headquartered in Craigavon Northern Ireland, is
celebrating another highly impressive year after being named 'Business of the
Year' (for the second time in 3 years), together with other significant
accolades at the Northern Ireland business awards - run by the nation's main
daily newspaper, The Belfast Telegraph in association with BMI (British
Midland International).
CRAIGAVON, Northern Ireland, April 4, 2011 - New Study findings published in Clinical Cancer Research - The Journal of
the American Association of Cancer Research (AACR)
Scientists from the School of Pharmacy at Queen's University Belfast and
Almac Discovery Ltd, announce the first publication describing a potential
new anti-angiogenic therapy based on a natural protein first discovered at
QUB.
More News
- Almac Open CLIA lab for Biomarker Clinical Trials
- BioFocus and Almac Collaborate to Offer Fluorescent Lifetime Assays
- Almac Announces Expansion to its Commercial Facility With the Addition of Increased Storage Capacity for Biologic Products
- Almac - The A to ZED of Automated Walleting for Clinical Trial Supply
- Almac Your Bioinformatics Partner
- Accolade Recognises Strong Communication of Almac's Integrated Services and US Expansion Programmes
- Almac Adds Late Stage Customisation Suite to Assist Orphan Drug / Niche Product Launches Into Europe
- Almac and the Royal Society of Chemistry Host a Workshop on the use of Analytical Techniques to Control and Monitor Solid Form
- Almac has Successful MHRA Inspection at its Clinical Services UK Site
- Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment
- Almac Launch Biomarkers for Biopharma